RARRES2 and ovarian cancer: As reviewed in greater detail by Treeck et al. [13], an analysis of microarray data from 1656 ovarian cancer patients showed that RARRES2, CMKLR1, and GPR1 amounts were lower in ovarian cancer tissue than in the normal one, and CCRL2 values were comparable in normal and cancerous tissue.